SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2qr7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AV2_D_DVAD8_0
(GRAMICIDIN A)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
3 / 3 VAL A 606
VAL A 656
TRP A 602
None
0.89A 1av2C-2qr7A:
undetectable
1av2D-2qr7A:
undetectable
1av2C-2qr7A:
4.68
1av2D-2qr7A:
4.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HRK_A_CHDA1502_0
(FERROCHELATASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 8 LEU A 502
VAL A 606
GLY A 605
TRP A 602
None
1.00A 1hrkA-2qr7A:
undetectable
1hrkA-2qr7A:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1HRK_B_CHDB2502_0
(FERROCHELATASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 8 LEU A 502
VAL A 606
GLY A 605
TRP A 602
None
0.99A 1hrkB-2qr7A:
undetectable
1hrkB-2qr7A:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1M17_A_AQ4A999_1
(EPIDERMAL GROWTH
FACTOR RECEPTOR)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
7 / 12 ALA A 449
LYS A 451
GLU A 463
THR A 493
LEU A 495
MET A 496
ASP A 561
None
0.64A 1m17A-2qr7A:
21.3
1m17A-2qr7A:
25.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_A_BAXA1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 ALA A 449
GLU A 463
LEU A 467
THR A 493
LEU A 530
HIS A 537
None
0.66A 1uwhA-2qr7A:
20.4
1uwhA-2qr7A:
24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_B_BAXB1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
7 / 12 ALA A 449
LYS A 451
GLU A 463
LEU A 467
THR A 493
LEU A 530
HIS A 537
None
0.63A 1uwhB-2qr7A:
20.4
1uwhB-2qr7A:
24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWJ_B_BAXB1723_1
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 ILE A 428
ALA A 449
GLU A 463
THR A 493
LEU A 530
HIS A 537
None
0.82A 1uwjB-2qr7A:
20.3
1uwjB-2qr7A:
24.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1W5U_D_DVAD8_0
(GRAMICIDIN D)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
3 / 3 VAL A 606
VAL A 656
TRP A 602
None
0.85A 1w5uC-2qr7A:
undetectable
1w5uD-2qr7A:
undetectable
1w5uC-2qr7A:
4.68
1w5uD-2qr7A:
4.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 12 GLY A 594
ALA A 597
ASP A 596
GLY A 534
ALA A 671
None
1.06A 2b7zA-2qr7A:
undetectable
2b7zA-2qr7A:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G70_A_SAMA2001_1
(PHENYLETHANOLAMINE
N-METHYLTRANSFERASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 7 TYR A 615
THR A 613
TYR A 609
ASN A 691
None
0.91A 2g70A-2qr7A:
undetectable
2g70A-2qr7A:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2G70_B_SAMB2002_1
(PHENYLETHANOLAMINE
N-METHYLTRANSFERASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 7 TYR A 615
THR A 613
TYR A 609
ASN A 691
None
0.89A 2g70B-2qr7A:
undetectable
2g70B-2qr7A:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IZQ_A_DVAA8_0
(GRAMICIDIN D)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
3 / 3 VAL A 656
TRP A 602
VAL A 606
None
0.89A 2izqA-2qr7A:
undetectable
2izqB-2qr7A:
undetectable
2izqA-2qr7A:
4.68
2izqB-2qr7A:
4.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NMZ_B_ROCB401_1
(PROTEASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 GLY A 594
ALA A 597
ASP A 596
ASP A 600
GLY A 534
ALA A 671
None
1.11A 2nmzA-2qr7A:
undetectable
2nmzA-2qr7A:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XKW_B_P1BB1475_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 6 LEU A 530
ILE A 559
ILE A 505
LEU A 608
None
0.81A 2xkwB-2qr7A:
undetectable
2xkwB-2qr7A:
24.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3B9L_A_AZZA1009_1
(SERUM ALBUMIN)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 8 GLU A 513
SER A 649
VAL A 673
HIS A 676
None
1.26A 3b9lA-2qr7A:
undetectable
3b9lA-2qr7A:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DEU_A_SALA305_1
(TRANSCRIPTIONAL
REGULATOR SLYA)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 7 VAL A 527
THR A 526
ILE A 523
ILE A 545
None
0.84A 3deuA-2qr7A:
undetectable
3deuA-2qr7A:
19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKX_B_1UNB201_1
(PROTEASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 11 GLY A 594
ALA A 597
ASP A 596
ASP A 600
VAL A 527
GLY A 534
None
1.48A 3ekxA-2qr7A:
undetectable
3ekxA-2qr7A:
14.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EL5_B_1UNB201_2
(PROTEASE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 GLY A 594
ALA A 597
ASP A 596
ASP A 600
VAL A 527
GLY A 534
None
1.46A 3el5B-2qr7A:
undetectable
3el5B-2qr7A:
14.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GCS_A_BAXA401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 12 ALA A 449
GLU A 463
LEU A 467
ILE A 477
THR A 493
None
0.92A 3gcsA-2qr7A:
18.9
3gcsA-2qr7A:
29.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GCS_A_BAXA401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 12 ALA A 449
LEU A 467
ILE A 477
THR A 493
HIS A 537
None
0.94A 3gcsA-2qr7A:
18.9
3gcsA-2qr7A:
29.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GP0_A_NILA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 11)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 ALA A 449
GLU A 463
LEU A 467
ILE A 477
THR A 493
HIS A 537
None
0.57A 3gp0A-2qr7A:
19.1
3gp0A-2qr7A:
29.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GP0_A_NILA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 11)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 GLU A 463
LEU A 467
ILE A 477
THR A 493
HIS A 537
ASP A 561
None
1.25A 3gp0A-2qr7A:
19.1
3gp0A-2qr7A:
29.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEC_A_STIA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
7 / 12 ALA A 449
LYS A 451
GLU A 463
LEU A 467
ILE A 477
THR A 493
LEU A 495
None
0.62A 3hecA-2qr7A:
19.2
3hecA-2qr7A:
29.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEG_A_BAXA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 ALA A 449
LYS A 451
GLU A 463
LEU A 467
ILE A 477
THR A 493
None
0.90A 3hegA-2qr7A:
2.5
3hegA-2qr7A:
29.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEG_A_BAXA1_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 ALA A 449
LYS A 451
GLU A 463
LEU A 467
THR A 493
MET A 496
None
1.30A 3hegA-2qr7A:
2.5
3hegA-2qr7A:
29.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L8L_D_DVAD8_0
(GRAMICIDIN D)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
3 / 3 VAL A 606
VAL A 656
TRP A 602
None
0.85A 3l8lC-2qr7A:
undetectable
3l8lD-2qr7A:
undetectable
3l8lC-2qr7A:
4.68
3l8lD-2qr7A:
4.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LFA_A_1N1A361_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 8 ALA A 449
LYS A 451
GLU A 463
THR A 493
LEU A 495
MET A 496
None
0.84A 3lfaA-2qr7A:
19.2
3lfaA-2qr7A:
29.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_A_1N1A1000_1
(P38A)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 GLY A 429
ALA A 449
LYS A 451
LEU A 467
ILE A 477
THR A 493
None
0.60A 3ohtA-2qr7A:
5.4
3ohtA-2qr7A:
28.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OHT_B_1N1B1000_1
(P38A)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 GLY A 429
ALA A 449
LYS A 451
LEU A 467
ILE A 477
THR A 493
None
0.58A 3ohtB-2qr7A:
5.4
3ohtB-2qr7A:
28.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W1W_A_CHDA1503_0
(FERROCHELATASE,
MITOCHONDRIAL)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 8 ILE A 545
VAL A 606
GLY A 605
TRP A 602
None
0.80A 3w1wA-2qr7A:
undetectable
3w1wA-2qr7A:
21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZOS_B_0LIB1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
7 / 12 ALA A 449
LYS A 451
GLU A 463
ILE A 477
THR A 493
LEU A 530
HIS A 537
None
0.71A 3zosB-2qr7A:
19.0
3zosB-2qr7A:
24.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_B_0LIB1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
7 / 12 ALA A 449
LYS A 451
GLU A 463
LEU A 467
ILE A 476
THR A 493
HIS A 537
None
0.59A 4c8bB-2qr7A:
20.3
4c8bB-2qr7A:
25.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QYN_A_RTLA201_0
(RETINOL-BINDING
PROTEIN 2)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 12 PHE A 562
ALA A 565
THR A 522
THR A 526
LEU A 540
None
1.28A 4qynA-2qr7A:
undetectable
4qynA-2qr7A:
16.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QZU_A_RTLA201_0
(RETINOL-BINDING
PROTEIN 2)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 12 PHE A 562
ALA A 565
THR A 522
THR A 526
LEU A 540
None
1.35A 4qzuA-2qr7A:
undetectable
4qzuA-2qr7A:
16.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RZ7_A_1E8A901_1
(CGMP-DEPENDENT
PROTEIN KINASE,
PUTATIVE)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
7 / 10 ILE A 428
ALA A 449
LYS A 451
ILE A 477
THR A 493
LEU A 495
LEU A 546
None
0.59A 4rz7A-2qr7A:
6.1
4rz7A-2qr7A:
17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 12 ALA A 449
LYS A 451
THR A 493
ASP A 561
PHE A 562
None
0.71A 4xv2A-2qr7A:
20.1
4xv2A-2qr7A:
25.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
6 / 12 ALA A 449
LYS A 451
LEU A 467
THR A 493
ASP A 561
PHE A 562
None
0.79A 4xv2B-2qr7A:
20.0
4xv2B-2qr7A:
25.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 12 ALA A 449
LYS A 451
LEU A 467
THR A 493
PHE A 562
None
0.80A 5cswA-2qr7A:
20.1
5cswA-2qr7A:
25.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 12 ALA A 449
LYS A 451
LEU A 467
THR A 493
PHE A 562
None
0.81A 5cswB-2qr7A:
20.0
5cswB-2qr7A:
25.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HI2_A_BAXA801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
7 / 12 ALA A 449
LYS A 451
GLU A 463
LEU A 467
THR A 493
LEU A 530
HIS A 537
None
0.70A 5hi2A-2qr7A:
20.9
5hi2A-2qr7A:
25.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_B_P06B801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 7 ILE A 428
GLY A 429
ASP A 561
PHE A 562
None
0.85A 5hieB-2qr7A:
19.7
5hieB-2qr7A:
24.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HIE_D_P06D801_2
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 8 ILE A 428
GLY A 429
ASP A 561
PHE A 562
None
0.83A 5hieD-2qr7A:
19.8
5hieD-2qr7A:
24.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5IZF_E_AZ1E2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
6J9-ZEU-DAR-ACA-DAR-
NH2)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 7 GLY A 429
GLY A 431
SER A 432
LYS A 451
None
0.72A 5izfA-2qr7A:
22.7
5izfA-2qr7A:
31.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5J5X_B_AZ1B2_1
(CAMP-DEPENDENT
PROTEIN KINASE
CATALYTIC SUBUNIT
ALPHA
47P-AZ1-DAL-DAR-DAR-
DAR-DAR)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
4 / 7 GLY A 429
GLY A 431
LYS A 451
ASP A 561
None
0.28A 5j5xA-2qr7A:
22.8
5j5xA-2qr7A:
31.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_B_ADNB401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 9 ILE A 428
GLY A 429
ALA A 449
ILE A 477
MET A 496
None
0.62A 5lw1B-2qr7A:
19.2
5lw1B-2qr7A:
13.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_E_ADNE401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)
2qr7 RIBOSOMAL PROTEIN S6
KINASE ALPHA-3

(Mus
musculus)
5 / 10 GLY A 429
ALA A 449
ILE A 477
LEU A 495
MET A 496
None
0.64A 5lw1E-2qr7A:
18.9
5lw1E-2qr7A:
13.45